COVID-19 Policy Update TUESDAY 4/13 TOP THREE Johnson & Johnson: The FDA and CDC recommended a pause on administering the J&J vaccine citing cases of a rare blood clot disorder experienced by six women (out of nearly 7 million administered doses)
COVID-19 Policy Update #232
COVID-19 Policy Update #232
COVID-19 Policy Update #232
COVID-19 Policy Update TUESDAY 4/13 TOP THREE Johnson & Johnson: The FDA and CDC recommended a pause on administering the J&J vaccine citing cases of a rare blood clot disorder experienced by six women (out of nearly 7 million administered doses)